Direct delivery
Cancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.
Using the body’s own defenses to combat cancer
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
Turning off cancer genes
RNA interference holds much promise as a cancer treatment, but technical challenges remain.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
A new target for cancer drugs
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
More than just a pretty flower
MIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.
Cancer’s hiding spots revealed
Discovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.
New Koch Institute building to open soon
Researchers will start moving into the 365,000-square-foot building next week.
MIT Medical promotes employee mammograms
No referral or copay for female employees between 40 and 70 who are enrolled in any MIT-sponsored health-insurance plan.
Surprising similarities between human and zebrafish tumors
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
New nanoparticles could improve cancer treatment
Particles can deliver a combination of chemotherapy drugs directly to prostate-cancer cells.
Getting bacteria to do a plant’s job
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
An unexpected twist in cancer metabolism
A cancer-cell quirk could be exploited to develop new drugs that starve tumors.
From sponges, a potential cancer drug
MIT chemists have synthesized a family of natural compounds that have shown promise in killing tumor cells.